Human papillomavirus testing on self‐collected samples to detect high‐grade cervical lesions in rural Bhutan: The REACH‐Bhutan study
Cancer Medicine · 2023
DOI: 10.1002/cam4.5851 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Gary M Clifford und 10 weiteren Autor:innen. Beteiligte Einrichtung: Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Uterine Cervical Dysplasia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: World Health Organization, Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
Background “REACH‐Bhutan” aimed to evaluate the feasibility and clinical performance of a community‐based screening program for cervical cancer in rural Bhutan using self‐collected samples for high‐risk human papillomavirus (HR‐HPV) testing.
Methods
In April/May 2016, 2590 women aged 30–60 years were screened across rural Bhutan by providing a self‐collected sample for care HPV testing. All care HPV‐positive women, plus a random sample of care HPV‐negative women, were recalled for colposcopy and biopsy. Self‐samples also underwent GP5+/6+ polymerase chain reaction (PCR)‐based HR‐HPV DNA detection and genotyping. Cross‐sectional screening indices were estimated against histological high‐grade squamous intraepithelial lesions or worse (hHSIL+), including imputation of hHSIL+ in women without colposcopy.
Results
HR‐HPV positivity was 10.2% by care HPV and 14.8% by GP5+/6+ PCR. Twenty‐two cases of hHSIL+ were histologically diagnosed, including one invasive cancer; an additional 7 hHSIL+ were imputed in women without colposcopy. HR‐HPV testing by GP5+/6+ showed higher sensitivity for hHSIL+ (89.7%, 95% CI 72.6–97.8) than care HPV (75.9%, 95% CI 56.5–89.7). Negative predictive value was also slightly higher for GP5+/6+ (99.9%, 95% CI 99.6–100) than care HPV (99.7%, 95% CI 99.4–99.9). Specificity, however, was lower for GP5+/6+ (86.1%, 95% CI 84.6–87.4) than care HPV (90.6%, 95% CI 89.4–91.7), as was positive predictive value (6.9%, 95% CI 4.5–9.9 vs. 8.5%, 95% CI 5.4–12.6). Of 377 HR‐HPV‐positive women by GP5+/6+, 173 (45.9%) were care HPV‐positive, including 54.7% HPV16‐positive and 30.2% HPV18‐positive women.
Conclusions
The final REACH‐Bhutan results show that screening for cervical cancer with self‐collection of samples and HR‐HPV testing, in addition to our previous report of achieving high participation, can also perform well to detect women with hHSIL+.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
- Department of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
- Department of Obstetrics & Gynaecology, Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan.
- Department of Pathology & Laboratory Medicine, Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan.
- Cancer Epidemiology Unit, "Città della Salute e della Scienza" Hospital, Turin, Italy.
ORCID-Profile: Gary M Clifford
Förderung
- World Health Organization
- Bill and Melinda Gates Foundation
Zitieren
APA
Clifford, G. M., Baussano, I., Heideman, D. A. M., Tshering, S., Choden, T., Lazzarato, F., Tenet, V., Franceschi, S., Darragh, T. M., Tobgay, T., & Tshomo, U. (2023). Human papillomavirus testing on self‐collected samples to detect high‐grade cervical lesions in rural Bhutan: The REACH‐Bhutan study. Cancer Medicine. https://doi.org/10.1002/cam4.5851
Vancouver
Clifford GM, Baussano I, Heideman DAM, Tshering S, Choden T, Lazzarato F, et al. Human papillomavirus testing on self‐collected samples to detect high‐grade cervical lesions in rural Bhutan: The REACH‐Bhutan study. Cancer Medicine. 2023. doi:10.1002/cam4.5851
BibTeX
@article{Clifford2023,
author = {Clifford, Gary M and Baussano, Iacopo and Heideman, Daniëlle A M and Tshering, Sangay and Choden, Tashi and Lazzarato, Fulvio and Tenet, Vanessa and Franceschi, Silvia and Darragh, Teresa M and Tobgay, Tashi and Tshomo, Ugyen},
title = {Human papillomavirus testing on self‐collected samples to detect high‐grade cervical lesions in rural Bhutan: The REACH‐Bhutan study},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.5851}
}
EUVIMED